Valuation: Recordati

Market Cap 10.86B 12.1B 10B 9.09B 17.19B 1,135B 17.67B 120B 47.72B 608B 45.43B 44.46B 1,922B P/E 2026 *
21.6x
P/E 2027 * 17.6x
Enterprise Value 12.63B 14.08B 11.64B 10.57B 20B 1,320B 20.56B 139B 55.52B 707B 52.85B 51.73B 2,236B EV / Sales 2026 *
4.51x
EV / Sales 2027 * 4.07x
Free-Float
50.46%
Yield 2026 *
2.58%
Yield 2027 * 3.17%
1 day-0.19%
1 week+0.09%
3 months-0.47%
6 months+6.00%
Current year+9.19%
1 week 52.75
Extreme 52.75
53.25
1 month 52.75
Extreme 52.75
53.8
Current year 43.76
Extreme 43.76
53.8
1 year 43.76
Extreme 43.76
54.45
3 years 43.76
Extreme 43.76
60.95
5 years 34.52
Extreme 34.52
60.95
10 years 24.55
Extreme 24.55
60.95
Manager TitleAgeSince
Chief Executive Officer 64 01/12/2021
Director of Finance/CFO 56 01/01/2026
Chief Tech/Sci/R&D Officer 56 01/10/2023
Director TitleAgeSince
Chairman 55 01/12/2021
Chairman 57 12/06/2018
Director/Board Member 53 12/06/2018
Date Insider Type Main position Quantity % Market Cap. Importance
11/12/25
Arisca SRL
BuyCompany 10,071 0.0048%
11/12/25 Buy

Chief Financial Officer

2,000 0.0010%
11/12/25 Buy

Chief Financial Officer

2,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-0.19%+0.09%+6.60%+18.41% 12.18B
+1.66%+1.82%+48.45%+140.08% 1,258B
-0.37%+5.53%+49.09%+90.76% 679B
+0.17%+2.88%+34.54%+112.32% 518B
+0.17%+1.16%+49.70%+68.75% 390B
-1.10%+2.24%+70.50%+45.88% 367B
+0.76%+2.25%+31.84%+59.53% 307B
-1.29%+0.17%+7.63%+33.04% 293B
-0.00%+0.95%+43.87%+74.19% 252B
+1.71%+2.12%+44.75%+125.26% 210B
Average +0.22%+0.97%+38.70%+76.82% 429B
Weighted average by Cap. +0.47%+1.17%+44.32%+96.33%

Financials

2026 *2027 *
Net sales 2.8B 3.12B 2.58B 2.35B 4.44B 293B 4.56B 30.92B 12.32B 157B 11.73B 11.48B 496B 3.03B 3.38B 2.79B 2.53B 4.8B 317B 4.93B 33.41B 13.31B 170B 12.67B 12.4B 536B
Net income 569M 634M 524M 476M 901M 59.48B 926M 6.28B 2.5B 31.87B 2.38B 2.33B 101B 684M 763M 631M 573M 1.08B 71.53B 1.11B 7.55B 3.01B 38.32B 2.86B 2.8B 121B
Net Debt 1.77B 1.98B 1.63B 1.48B 2.81B 185B 2.89B 19.58B 7.8B 99.37B 7.42B 7.27B 314B 1.46B 1.63B 1.35B 1.22B 2.32B 153B 2.38B 16.13B 6.43B 81.89B 6.12B 5.99B 259B
Projected Income Statement - Annual - Recordati
Logo Recordati
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (58.7%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (41.3%). Net sales are distributed geographically as follows: Italy (12.6%), Europe (53.7%), America (23.1%), Asia and Oceania (7.8%) and Africa (2.8%).
Employees
4,654
Date Price Change Volume
10/11/26 €53.00 -0.19% 275,929
09/11/26 €53.10 -0.28% 185,374
06/11/26 €53.25 +0.38% 283,335
05/11/26 €53.05 -0.09% 223,602
04/11/26 €53.10 +0.19% 378,457
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Recordati
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
53.10EUR
Average target price
56.72EUR
Spread / Average Target
+6.83%